Bacteria-derived chimeric toxins as potential anticancer agents.

Cancer is one of the major causes of death globally, requiring everlasting efforts to develop novel, specific, effective, and safe treatment strategies. Despite advances in recent years, chemotherapy, as the primary treatment for cancer, still faces limitations such as the lack of specificity, drug resistance, and treatment failure. Bacterial toxins have great potential to be used as anticancer agents and can boost the effectiveness of cancer chemotherapeutics. Bacterial toxins exert anticancer effects by affecting the cell cycle and apoptotic pathways and regulating tumorigenesis. Chimeric toxins, which are recombinant derivatives of bacterial toxins, have been developed to address the low specificity of their conventional peers. Through their targeting moieties, chimeric toxins can specifically and effectively detect and kill cancer cells. This review takes a comprehensive look at the anticancer properties of bacteria-derived toxins and discusses their potential applications as therapeutic options for integrative cancer treatment.

Anticancer Compounds Derived from Marine Diatoms.

Cancer is the main cause of death worldwide, so the discovery of new and effective therapeutic agents must be urgently addressed. Diatoms are rich in minerals and secondary metabolites such as saturated and unsaturated fatty acids, esters, acyl lipids, sterols, proteins, and flavonoids. These bioactive compounds have been reported as potent anti-cancer, anti-oxidant and anti-bacterial agents. Diatoms are unicellular photosynthetic organisms, which are important in the biogeochemical circulation of silica, nitrogen, and carbon, attributable to their short growth-cycle and high yield. The biosilica of diatoms is potentially effective as a carrier for targeted drug delivery in cancer therapy due to its high surface area, nano-porosity, bio-compatibility, and bio-degradability. In vivo studies have shown no significant symptoms of tissue damage in animal models, suggesting the suitability of a diatoms-based system as a safe nanocarrier in nano-medicine applications. This review presents an overview of diatoms' microalgae possessing anti-cancer activities and the potential role of the diatoms and biosilica in the delivery of anticancer drugs. Diatoms-based antibodies and vitamin B12 as drug carriers are also elaborated.

Cellulose-hydroxyapatite carbon electrode composite for trace plumbum ions detection in aqueous and palm oil mill effluent: Interference, optimization and validation studies.

Environmental monitoring is important to determine the extent of eco-system pollution and degradation so that effective remedial strategies can be formulated. In this study, an environmentally friendly and cost-effective sensor made up of novel carbon electrode modified with cellulose and hydroxyapatite was developed for the detection of trace lead ions in aqueous system and palm oil mill effluent. Zinc, cadmium, and copper with lead were simultaneously detected using this method. The electrode exhibited high tolerance towards twelve common metal ions and three model surface active substances - sodium dodecyl sulfate, Triton X-100, and cetyltrimethylammonium bromide. Under optimum conditions, the sensor detected lead ions in palm oil mill effluent in the concentration range of 10-50 µg/L with 0.11 ±â€¯0.37 µg/L limit of detection and 0.37 ±â€¯0.37 µg/L limit of quantification. The validation using tap water, blood serum and palm oil mill effluent samples and compared with Atomic Absorption Spectroscopy, suggested excellent sensitivity of the sensor to detect lead ions in simple and complex matrices. The cellulose produced based on "green" techniques from agro-lignocellulosic wastes, in combination with hydroxyapatite, were proven effective as components in the carbon electrode composite. It has great potential in both clinical and environmental use.